Direct oral anticoagulants (DOACs) are increasingly being used in the elderly population in view of its ease of use, efficacy, and favorable side‐effect profile compared with the vitamin K antagonists. However, there is a need for increase awareness of well‐characterized cases, albeit a small number, of bullous pemphigoid‐like skin reactions associated with rivaroxaban.